Hereditary folate malabsorption: A Patient Guide

Hereditary Folate Malabsorption (HFM) is an extremely rare genetic condition that fundamentally changes how a child’s body interacts with one of its most essential nutrients: folate, or Vitamin B9. At the heart of this condition are pathogenic variants in the SLC46A1 gene, which is responsible for creating a specialized protein called the Proton-Coupled Folate Transporter (PCFT). Normally, these proteins act as transporters that pull folate from the digestive tract into the bloodstream and, crucially, transport it from the blood into the cerebrospinal fluid (CSF) that surrounds the brain. In children with HFM, these transporters are impaired or missing, creating a “double-block” that deprives both the body and the central nervous system of the folate they need to grow and function ^[1][2].

Because mothers provide their babies with folate stores during pregnancy, infants with HFM often have an initially symptom-free period and are typically born appearing healthy. However, as they grow rapidly during those first few months of life, they use those maternal stores. Since their bodies cannot adequately absorb new folate from breast milk or formula, they may begin to experience a cascade of symptoms in early infancy, ranging from severe anemia and failure to thrive to frequent infections and neurological signs like seizures or developmental delays ^[3][4]. This initially symptom-free start followed by a decline is a hallmark of how HFM behaves as the child’s natural folate stores run low.

A major challenge in navigating this diagnosis is that standard blood tests do not always tell the full story. It is possible for a child with HFM to have folate levels in their blood that appear “normal” (due to recent diet or treatment) while the folate levels in their cerebrospinal fluid are still deficient. This happens because the barrier protecting the brain is even harder for folate to cross than the lining of the gut. Consequently, doctors must look beyond simple blood markers and evaluate the complete clinical picture, often using specialized tests such as a lumbar puncture (spinal tap) to measure the actual folate environment of the central nervous system to ensure it is receiving the nourishment it requires ^[4][5].

The path forward for a child with HFM centers on a very specific, prescription form of treatment known as folinic acid. Unlike standard, over-the-counter folic acid, which often fails in these children because it relies too heavily on the impaired PCFT transporter, high-dose folinic acid can use alternative pathways to reach the cells. Because the central nervous system is so difficult to reach, this medication is often given by injection to ensure enough of it crosses the blood-brain barrier. When treatment is started early and maintained with strict consistency, it can improve blood abnormalities and may prevent or improve neurological disease. While HFM requires lifelong care and careful monitoring, bypassing the genetic block with the right medication offers a clear and hopeful way for children to develop ^[5][6].